[ Price : $8.95]
The National Cancer Institute says Syndax Pharmaceuticals revumenib shows promise in treating some acute myeloid leukemias.[ Price : $8.95]
FDA says drug compounders should be sure the active pharmaceutical ingredients and excipients they use have been evaluated by thei...[ Price : $8.95]
ProPublica says FDA foreign drug manufacturer inspections remain well below pre-pandemic inspection levels.[ Price : $8.95]
Sidley attorneys say a new FDA final guidance on a risk-based approach to clinical trial oversight is significant for trial sponso...[ Price : $8.95]
Generic mifepristone maker GenBioPro sues FDA to block the agency from taking any actions against the company if a pending court o...[ Price : $8.95]
FDA approves an expanded indication for AbbVies Qulipta to prevent chronic migraines.[ Price : $8.95]
The U.S. Supreme Court extends by two days (until 4/21) its administrative stay of a lower courts 4/7 order that would restrict th...[ Price : $8.95]
An ongoing European Medicines Agency and FDA joint initiative on information sharing involving generic drug bioequivalence study i...